100 related articles for article (PubMed ID: 7193368)
1. [Hormone therapy of prostatic cancer (author's transl)].
Altwein JE; Jacobi GH
Urologe A; 1980 Nov; 19(6):350-7. PubMed ID: 7193368
[TBL] [Abstract][Full Text] [Related]
2. [Current aspects of hormonal therapy in prostate cancer].
Altwein JE
Helv Chir Acta; 1981 Aug; 48(3-4):391-5. PubMed ID: 7287476
[TBL] [Abstract][Full Text] [Related]
3. [Serum prolactin levels during therapy of prostatic cancer with oestradiol-17 beta-undecylate and cyproterone acetate (author's transl)].
Spona J; Lunglmayr G
Wien Klin Wochenschr; 1980 Jul; 92(14):494-7. PubMed ID: 6933738
[TBL] [Abstract][Full Text] [Related]
4. [Clinical protocols in treatment of prostatic carcinoma in Europe. The role of EORTC and other organizations].
Newling DW
Urologe A; 1995 Sep; 34(5):374-81. PubMed ID: 7483153
[TBL] [Abstract][Full Text] [Related]
5. VACURG studies of conservative treatment.
Byar DP
Scand J Urol Nephrol Suppl; 1980; 55():99-102. PubMed ID: 6938045
[TBL] [Abstract][Full Text] [Related]
6. EORTC protocols in prostatic cancer. An interim report.
Pavone-Macaluso M; Lund F; Mulder JH; Smith PH; De Pauw M; Sylvester R
Scand J Urol Nephrol Suppl; 1980; 55():163-8. PubMed ID: 6938020
[TBL] [Abstract][Full Text] [Related]
7. Orchiectomy.
Alfthan O
Scand J Urol Nephrol Suppl; 1980; 55():117-20. PubMed ID: 6259721
[TBL] [Abstract][Full Text] [Related]
8. New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Jacobi GH; Wenderoth UK
Prog Clin Biol Res; 1984; 153():529-45. PubMed ID: 6236463
[No Abstract] [Full Text] [Related]
9. Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.
Grande M; Carlström K; Rozell BL; Stege R; Pousette A
Clin Cancer Res; 2000 May; 6(5):1790-5. PubMed ID: 10815899
[TBL] [Abstract][Full Text] [Related]
10. The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium.
Mikkola A; Ruutu M; Aro J; Rannikko S; Salo J
Ann Chir Gynaecol; 1999; 88(1):18-21. PubMed ID: 10230677
[TBL] [Abstract][Full Text] [Related]
11. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
Scherr DS; Pitts WR
J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
[TBL] [Abstract][Full Text] [Related]
12. A randomized phase II trial of flutamide vs chlormadinone acetate in previously untreated advanced prostatic cancer. The Japan Flutamide Study Group.
Akaza H; Usami M; Kotake T; Koiso K; Aso Y
Jpn J Clin Oncol; 1993 Jun; 23(3):178-85. PubMed ID: 7688829
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic options in advanced cancer of the prostate].
Schmid HP; Bitton A
Praxis (Bern 1994); 1997 Oct; 86(44):1734-9. PubMed ID: 9446174
[TBL] [Abstract][Full Text] [Related]
14. [Medical treatment of prostate cancer].
Lobel B; Cipolla B; Labrador J
Rev Prat; 1994 Mar; 44(5):611-5. PubMed ID: 8066398
[TBL] [Abstract][Full Text] [Related]
15. Endocrine treatment of prostate cancer.
Tammela T
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of the carcinoma of the prostate with gestagens (author's transl)].
Popelier G
Urologe A; 1973 May; 12(3):134-9. PubMed ID: 4127418
[No Abstract] [Full Text] [Related]
17. [Possibilities in drug therapy in prostatic carcinoma].
Schmid HP
Ther Umsch; 1995 Jun; 52(6):418-22. PubMed ID: 7541571
[TBL] [Abstract][Full Text] [Related]
18. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of prostatic cancer: medroxyprogesterone acetate, diethylstilbestrol and cyproterone acetate. Provisional report of a random study by the genito-urinary cooperative group of the EORTC].
Pavone-Macaluso M; Martínez-Piñeiro JA; de Voogt H; Lardennois B; Nasta A; Zolfanelli R; Barasolo E; De Pauw M; Suciu S; Sulvester R
Arch Esp Urol; 1982; 35(5):304-11. PubMed ID: 6217788
[No Abstract] [Full Text] [Related]
20. [Basic principles and initial results of adjuvant hormone therapy and irradiation of prostatic carcinoma].
Dearnaley DP; Shearer RJ; Ellingham L; Gadd J; Horwich A
Praxis (Bern 1994); 1997 Nov; 86(48):1895-901. PubMed ID: 9480509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]